background

Small Molecules

Integrated Small Molecule Oversight: Discovery to Commercial Launch

Integrated Small Molecule Oversight: Discovery to Commercial Launch

Small Molecules

Bridging the gap between lab-scale discovery and GMP reality. We provide the independent vetting and on-ground governance required to navigate India’s ecosystem with absolute certainty. We offer the full small molecule lifecycle-from target validation and early discovery through IND-enabling studies, CMC, and commercial manufacturing.

    The "Aventiq Advantage"

  • Integrated IDDD Model:
    A single point of coordination for your entire development lifecycle.

  • Independent Governance:
    Unbiased partner vetting and "Person-in-Plant" oversight to protect your IP and data.

  • Regulatory Certainty:
    Ensuring every milestone-from MedChem to CMC-is USFDA/EMA submission-ready.

about

 

Technical Capability Matrix

Our vetted partner network supports complex synthetic transformations and challenging chemistries.

Complex Chemistries

Chiral Synthesis (Asymmetric), Catalysis, Organometallics, & High-Pressure Reactions.

Hazardous Processes

Azide Chemistry, Nitration, Halogenation, & Cryogenic Reactions ($-78^{\circ}C$).

Advanced Separation

Preparative HPLC, Chiral Resolution, & Simulated Moving Bed (SMB) Chromatography.

Solid State

Polymorph Screening, Salt Selection, & Micronization Oversight.

Discovery Chemistry & Medicinal Chemistry Advisory

"Leverage deep Indian expertise in hit identification and lead optimization at a 40–60% cost advantage."

Strategic Sourcing:

Expert partner scouting and technical vetting for medicinal chemistry programs.

Medicinal Chemistry:

High-level advisory for hit-to-lead (H2L), lead optimization, and SAR studies.

Custom Synthesis:

Oversight of complex molecule synthesis including libraries, analogs, and reference standards.

Model Guidance:

Consultation on FTE (Full-Time Equivalent) models and IP-secure vendor selection.

  • The Aventiq Edge: Early-stage route scouting conducted during discovery to identify and eliminate downstream scalability bottlenecks.

Discovery Biology & Early Screening Advisory

"Access world-class in vitro platforms and robust target validation capabilities."

Key Services:

    Platform Identification: Vendor scouting for specialized in vitro assays, target validation, and biomarker studies.

    Assay Oversight: Technical management of assay development/transfer and rigorous data integrity verification.

    Screening Qualification: Partner vetting for biochemical, cell-based, and phenotypic screening platforms.

    Lead Profiling: Expert guidance on early hit validation and selectivity profiling to ensure candidate quality.

The Aventiq Edge: Independent reproducibility audits that ensure your lead compounds are built on a foundation of flawless, verifiable biological data.

All engagements are confidential. No information is shared without written consent.